Key result
Mesenchymal stem cells from various sources aid cardiac regeneration over 6 years (2010–2015) by revitalizing cardiac stem cells or revascularizing heart vessels, though challenges remain.
Mesenchymal stem cells have been used for cardiovascular regenerative therapy for decades. These cells have been established as one of the potential therapeutic agents, following several tests in animal models and clinical trials. In the process, various sources of mesenchymal stem cells have been identified which help in cardiac regeneration by either revitalizing the cardiac stem cells or revascularizing the arteries and veins of the heart. Although mesenchymal cell therapy has achieved considerable admiration, some challenges still remain that need to be overcome in order to establish it as a successful technique. This in-depth review is an attempt to summarize the major sources of mesenchymal stem cells involved in myocardial regeneration, the significant mechanisms involved in the process with a focus on studies (human and animal) conducted in the last 6 years and the challenges that remain to be addressed.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2016) conducted a review in Cardiovascular disease requiring myocardial regeneration. Mesenchymal stem cells was evaluated. Mesenchymal stem cells from various sources aid cardiac regeneration over 6 years (2010–2015) by revitalizing cardiac stem cells or revascularizing heart vessels, though challenges remain.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: